neuroVasix
MicroVas - neuroVasix
exclusive worldwide marketers of
MicroVas innovation
about us
about neuroVasix
As a privately owned company with the EXCLUSIVE MARKETING RIGHTS TO THE MICROVAS TECHNOLOGY, it has sold and supports almost 1,000 systems in many markets, having sold systems to medical doctors, osteopathic physicians, podiatrists, physical therapists, various clinics, hospitals, veteran homes, nursing homes, professional athletes and sports teams. As neuroVasix expands its sales, each of these markets will continue to be of significant importance. Currently, management is focusing its sales efforts in three major areas: treatment of neuropathy, treatment of wounds, and podiatry.
Investor Relations
President/CEO
Stuart Baumgarten
(407) 435-8424
click envelope to send email
Investor Relations
President/CEO
Stuart Baumgarten
(407) 435-8424
click envelope to send email
about the MicroVas system
a patented, FDA 510-K registered, non-invasive device that delivers electrical currents to targeted areas of the human body. MicroVas delivers a powerful, deeply penetrating electrical waveform that causes blood to pump more efficiently through the micro circulation (drain the venous beds and raise tissue oxygen levels) in damaged tissue to accelerate the healing process. MicroVas’ therapeutic effects are dramatic and lasting. Healthcare professionals familiar with MicroVas consider it an important new tool in the treatment of neuropathy, non-healing wounds, repetitive motion disorders, fibromyalgia, sports injuries and many other conditions related to vascular insufficiency.
neuroVasix
Tel (918) 249-3784
Fax (888) 258-0041
info@microvas.info
